Medication info

Aclovir Tablet (Acyclovir)

Prescription medicationTabletIntravenous injectionExpired
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Medix Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets - 30 tablets/bottle, 200 tablets - 200 tablets/bottle
Approval status
Expired

MFDS item code 201901088 · Approved 2019.02.22

This product's status changed to Expired on 2024.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex (such as genital herpes); treatment of chickenpox
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in severe primary infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to begin treatment as soon as possible after infection. For recurrent infections, administration at the first sign of prodromal symptoms or lesions is recommended. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine 4 times daily at intervals of approximately 6 hours. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine 4 times daily at intervals of approximately 6 hours. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine 5 times daily at intervals of approximately 4 hours, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal absorption disorders. 3) It is best to begin treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse neuropsychiatric reactions; use caution by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg of this medicine twice daily at intervals of approximately 12 hours. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg of this medicine 3 times daily at intervals of approximately 8 hours.
Child administration
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as the adult dose. Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Medix Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex (such as genital herpes); treatment of chickenpox

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucosal tissues
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is effective for the treatment and prevention of infections caused by the herpes simplex virus, including primary and recurrent genital herpes, on skin and mucosal tissues. It is also used for the treatment of herpes zoster infections, particularly helpful in alleviating acute pain. However, its effectiveness for postherpetic neuralgia has not been clearly established. Additionally, it is used for the treatment of chickenpox in children over 2 years of age. This medication is effective for viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in severe primary infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to begin treatment as soon as possible after infection. For recurrent infections, administration at the first sign of prodromal symptoms or lesions is recommended. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine 4 times daily at intervals of approximately 6 hours. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine 4 times daily at intervals of approximately 6 hours. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine 5 times daily at intervals of approximately 4 hours, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal absorption disorders. 3) It is best to begin treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse neuropsychiatric reactions; use caution by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg of this medicine twice daily at intervals of approximately 12 hours. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg of this medicine 3 times daily at intervals of approximately 8 hours.

Child administration

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as the adult dose. Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medicine should not be used by patients who are allergic to this drug or its components, or who have had hypersensitivity reactions to valacyclovir. Patients with renal impairment may experience neurological side effects when using this medication, so caution is necessary. Patients with compromised liver function should use this medication cautiously, as it may worsen liver function. Particular care is needed when administering this medication to infants or children, and it is advisable to use the lowest necessary dose. Elderly individuals often have decreased renal function, which may lead to increased blood concentrations and a greater risk of side effects, requiring caution while using this medication. Severe allergic reactions such as shock, difficulty breathing, and hypotension may rarely occur during the use of this medication; if these symptoms appear, treatment should be discontinued immediately, and medical advice should be sought. Hypersensitivity reactions such as skin rashes, fever, urticaria, and blisters may also occur, and if these symptoms arise, the medication should be stopped. Alopecia, dermatitis, and severe skin diseases have also been reported, hence, skin condition changes should be monitored. Neurological symptoms may include altered consciousness, confusion, hallucinations, seizures, anxiety, drowsiness, and more, particularly in patients with renal impairment or elderly patients. In cases of renal impairment, signs of renal failure, hematuria, and proteinuria may occur, necessitating periodic monitoring of renal status. Blood-related side effects may include leukopenia, anemia, and platelet abnormalities, possibly requiring blood tests. Liver function abnormalities or jaundice symptoms may arise, necessitating regular liver function tests. Gastrointestinal symptoms may include gastritis, nausea, vomiting, and abdominal pain; if severe, medication should be stopped. Systemic symptoms may include fever, malaise, and headache, warranting consultation with medical personnel if abnormalities appear. Musculoskeletal side effects may include arthralgia and myalgia. Cardiac and circulatory side effects may present as arrhythmias, blood pressure changes, and chest pain, requiring caution. Genitourinary issues such as urinary difficulty or urinary obstruction may rarely occur. Other reported side effects include pneumonia, difficulty breathing, visual disturbances, hair loss, and hyponatremia. This medication is most effective when administered early in the symptomatic phase, and treatment should ideally begin within a certain period after the onset of symptoms. Immunocompromised patients may consider intravenous medication. Sufficient hydration is required during administration to prevent dehydration, which can reduce the risk of renal toxicity. In the treatment of recurrent genital herpes, the need for continued use after long-term administration should be evaluated. While taking this medication, altered consciousness may occur; thus, driving or operating hazardous machinery should be avoided. Interactions may occur when combined with other medications, particularly those affecting renal function; caution is warranted when used with such drugs. Pregnant women or those who could become pregnant should carefully consider the risks and benefits of using this medication. Women who are breastfeeding should discontinue breastfeeding during treatment, as the components of this drug may be excreted in breast milk. For infants and children, administration should only occur as necessary and at the minimal dose possible, as safety has not been fully established. Elderly patients may have increased drug concentrations due to decreased renal function; thus, dosage and intervals should be adjusted along with adequate hydration. In cases of overdose, confusion, seizures, and coma may occur, with potential risks of renal failure; immediate medical attention is required. In the event of overdose, blood drug concentrations should be monitored closely, and treatments such as blood dialysis may need to be considered.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • pressure sensation in the chest
  • phototoxic reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 116 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration impairment
  • aggressive behavior
  • depersonalization
  • agitation
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary erythrocyte casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function test results
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • weakness
  • malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • ureteral obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbance
  • taste disorder
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum proteins
  • elevated total cholesterol level
  • elevated triglyceride level
  • increased serum potassium level
  • decreased serum albumin level
  • agitation
  • coma
  • convulsions
  • somnolence
  • confusion
  • hallucinations
  • excitement
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from exposure to air or moisture. It is best to maintain the storage temperature between 1 and 30 degrees Celsius (room temperature).

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets - 30 tablets/bottle, 200 tablets - 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.